세계의 바이오인포매틱스 시장 규모는 2023년 187억 달러에서 예측 기간 중 13.6%의 CAGR로 추이하며, 2028년말에는 355억 달러 규모로 성장할 것으로 예측됩니다.
유전체학 용도용 바이오인포매틱스 시장 규모는 2023년 47억 달러에서 14.1%의 CAGR로 추이하며, 2028년말에는 90억 달러 규모로 성장할 것으로 예측됩니다. 또한 단백질체학 용도용 바이오인포매틱스 시장 규모는 2023년 31억 달러에서 13.8%의 CAGR로 추이하며, 2028년말에는 59억 달러 규모로 성장할 것으로 예측됩니다.
세계의 바이오인포매틱스 시장을 조사했으며, 시장 및 기술의 개요, 시장 영향요인 및 시장 기회 분석, 시장 규모의 추이·예측, 각종 구분·지역별 상세 분석, 기술 및 특허의 동향, ESG 개발, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.
목차
제1장 서론
제2장 요약·하이라이트
시장 전망
시장 개요
제3장 시장 개요
바이오로지컬 데이터 소스
시스템 바이올로지용 바이오인포매틱스
정밀의료용 바이오인포매틱스
의약품 개발용 바이오인포매틱스
화학정보학
차세대 시퀀싱
메타유전체학용 바이오인포매틱스
데이터베이스 관리 시스템용 바이오인포매틱스
시장 동향
정밀의료와 바이오마커 식별
클라우드 기반 솔루션
가치에 기반한 케어로의 이동
ChatGPT의 부상
시장이 해결해야 할 과제
데이터 통합
데이터 신뢰성과 표준화
엔드 투 엔드 워크플로우
바이오인포매틱스 툴 및 소프트웨어의 시장 동향
구매 요인 분석
실험 데이터 분석
제4장 시장 역학
개요
시장 촉진요인
시장 억제요인
시장 기회
제5장 시장 내역 : 용도별
개요
정보 과다
데이터량
데이터 다양성
데이터 속도
데이터 진실성
소프트웨어 확장성과 유효성
세계의 바이오인포매틱스 시장 : 용도별
유전체학
단백질체학
전사체학
대사체학
케미인포매틱스
약물유전체학
메타유전체학
기타 용도
제6장 시퀀싱 서비스 및 플랫폼 시장
개요
세계의 시퀀싱 서비스와 및 플랫폼 시장
시퀀싱 서비스
시퀀싱 플랫폼
제7장 시장 내역 : 솔루션별
개요
세계의 바이오인포매틱스 시장 : 솔루션별
서비스
소프트웨어
하드웨어와 부문
제8장 시장 내역 : 최종 사용별
개요
세계의 바이오인포매틱스 시장 : 최종 사용별
연구
임상·의료
기타
제9장 시장 내역 : 지역별
개요
세계의 바이오인포매틱스 시장 : 지역별
북미
유럽
아시아태평양
기타 지역
제10장 ESG 개발
바이오인포매틱스 기술 제조업에서 ESG의 중요성
ESG 평가와 지표 : 데이터 이해
바이오인포매틱스 기술 제조업에서 ESG의 실천
환경면 퍼포먼스
사회면 퍼포먼스
거버넌스면 퍼포먼스
사례 연구
BCC에 의한 견해
제11장 의약품 R&D용 바이오인포매틱스의 응용
Drug Discovery·개발 프로세스
표적 특정
표적 검증
리드 특정
리드의 최적화
임상 조사 : 의약품 개발
전임상 실험
신약 임상시험 신청
임상시험
신약 신청
NDA 승인
발매 후 지속적 연구와 제IV상 임상시험
전자건강기록
모바일 헬스 기술
최근 제약 및 바이오인포매틱스 제휴 및 파트너십
결론
제12장 새로운 기술과 개발
바이오인포매틱스 기술의 새로운 동향
데이터 사이언스 : 새로운 기술의 시대
소프트 컴퓨팅 어프로치
과제와 향후 연구 방향성
제13장 새로운 소프트웨어에 관한 정성적 정보
FastFinder
WorkFlow Language
Seven Bridges Platform
제14장 M&A와 벤처 자금조달 전망
M&A 분석
연구 보조금
공적자금
민간 자금
제15장 경쟁 정보
개요
세계의 기업 순위 분석
제16장 기업 개요
3RD MILLENNIUM INC.
AITIA
AGILENT TECHNOLOGIES INC.
ARAGEN LIFE SCIENCES LTD.
BIOMATTERS LTD.(GENEIOUS)
BIO-RAD(ABD SEROTEC)
BIO-TECHNE
COMPUGEN LTD.
DASSAULT SYSTEMES BIOVIA
DNASTAR INC.
GENEDATA AG
GENEVA BIOINFORMATICS(GENEBIO) SA
ILLUMINA INC.
INTE : LIGAND SOFTWARE ENTWICKLUNGS UND CONSULTING GMBH
MACVECTOR INC.
MOLECULAR CONNECTIONS PVT. LTD.
MOLECULAR NETWORKS GMBH
NONLINEAR DYNAMICS LTD.
OCIMUM BIOSOLUTIONS LTD.
PERKINELMER INFORMATICS INC.
PERSONALIS INC.
QLUCORE AB
REAL TIME GENOMICS INC.
SMARTGENE SERVICES SARL
SYNGENE INTERNATIONAL LTD.
THERMO FISHER SCIENTIFIC INC.
제17장 부록 : 두자어
KSA
영문 목차
영문목차
Highlights:
The global market for bioinformatics is expected to grow from $18.7 billion in 2023 to $35.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 13.6% during the forecast period of 2023-2028.
The global market for bioinformatics in genomics applications is expected to grow from $4.7 billion in 2023 to $9.0 billion by the end of 2028, at a CAGR of 14.1% during the forecast period of 2023-2028.
The global market for bioinformatics in proteomics applications is expected to grow from $3.1 billion in 2023 to $5.9 billion by the end of 2028, at a CAGR of 13.8% during the forecast period of 2023-2028.
Report Scope:
The scope of the study encompasses the global bioinformatics market based on geography, category and application. It provides a detailed analysis of recent advances in omic technologies and examines their impact on the bioinformatics market. It discusses the ways in which bioinformatics has been utilized by the pharma and biotech industries to streamline the research and development (R&D) process and improve efficiencies. It provides a detailed analysis of the leading countries, companies and technologies that will drive the field forward.
By solution, hardware application, sequencing services and platform, end user, and geography, the market has been segmented into the North America, Europe, Asia-Pacific and Rest of the World (RoW) regions. Detailed analysis of major countries such as the U.S., Germany, the UK, Italy, France, Spain, Japan, China, India, Brazil, Mexico, GCC countries and Australia will be covered in each country's respective regional segment. In the market valuations, 2022 serves as the base year, while estimated values are provided for 2023 and forecast values for 2028.
Report Includes:
123 data tables and 90 additional tables
An up-to-date overview and industry analysis of the global bioinformatics market
Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
Estimation of the market size and revenue forecast for the global bioinformatics market, and corresponding market share analysis based on solution, hardware type, application, sequencing services and platforms, end use, and region
In-depth information (facts and figures) concerning the major factors influencing the progress of this market (drivers, restraints, opportunities, and industry-specific challenges) with respect to specific growth trends, upcoming prospects, and contributions to the overall market
Coverage of information on the latest developments in the bioinformatics tools and services market, innovations in bioinformatics solutions for drug discovery, and details of antibody-based drug discovery and developments
Impact analysis of various region specific and industry specific macroeconomic variables on global bioinformatics market
Identification of the innovative companies and technologies that are moving forward in search for elusive pieces of information that will improve diagnoses and treatments of diseases with precision medicines
Understanding of the importance of ESG in the market for bioinformatics tools and services, consumer attitudes towards sustainability, risks & opportunity assessment, ratings and matrices, and ESG practices in global bioinformatics marketplace
A look at the major vendors in the global bioinformatics market, and analyze the structure of this industry with respect to company market shares, venture fundings, and recent M&A activities
Patent analysis covering significant allotments of recent patent grants across each major category
Profile descriptions of the leading market players
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in This Update?
Methodology
Information Sources
Geographic Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Market Summary
Chapter 3 Market Overview
Introduction
Biological Data Sources
Bioinformatics in Systems Biology
Bioinformatics in Precision Medicine
Bioinformatics in Drug Development
Cheminformatics
Next-Generation Sequencing
Bioinformatics in Metagenomics
Bioinformatics in Database Management Systems
Market Trends
Precision Medicine and Biomarker Identification
Cloud-Based Solutions
Shift Toward Value-Based Care
Rise of ChatGPT
Market Challenges
Data Integration
Data Reliability and Standardization
End-to-End Workflows
Market Trends in Bioinformatics Tools and Software
Purchasing Factors Analysis
Analyzing Experimental Data
Chapter 4 Market Dynamics
Overview
Market Drivers
New Discoveries in Biological Sciences
Increasing Use of Bioinformatics Analytical Software
New Antibody Technologies and Antibody Types
Antibody-Based Drug Discovery and Development
Developed and Increasing Research Areas
Increased Government Funding in Emerging Markets
Need for Further Human Genomic and Proteomic Research
New Application-Focused Technology Platforms
Market Restraints
Challenging Issues with Modeling Systems
Ethical Concerns with Bioinformatics and Computational Genomics
Market Opportunities
Market Expansion into Emerging Countries
Development of Novel Bioinformatics and Drugs
Chapter 5 Market Breakdown by Application
Overview
Information Overload
Data Volume
Data Variety
Data Velocity
Data Veracity
Software Scalability and Validity
Global Market for Bioinformatics, by Application
Genomics
Proteomics
Transcriptomics
Metabolomics
Cheminformatics
Pharmacogenomics
Metagenomics
Other Applications
Chapter 6 Market for Sequencing Services and Platforms
Overview
Global Market for Sequencing Services and Platforms
Sequencing Services
Sequencing Platforms
Chapter 7 Market Breakdown by Solution
Overview
Global Market for Bioinformatics, by Solution
Services
Software
Hardware and Its Segments
Chapter 8 Market Breakdown by End Use
Overview
Global Market for Bioinformatics, by End Use
Research
Clinical and Medical
Other End Uses
Chapter 9 Market Breakdown by Region
Overview
Global Market for Bioinformatics, by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 10 ESG Development
Importance of ESG in the Bioinformatics Technologies Manufacturing Industry
ESG Ratings and Metrics: Understanding the Data
ESG Practices in the Bioinformatics Technologies Manufacturing Industry
Environmental Performance
Social Performance
Governance Performance
Case Study
BCC Research Viewpoint
Chapter 11 Bioinformatics Applications in Pharmaceutical R&D
Introduction
Drug Discovery and Development Process
Target Identification
Target Validation
Lead Identification
Lead Optimization
Clinical Research: Drug Development
Preclinical Experiments
Investigational New Drug Applications
Clinical Trials
New Drug Application
NDA Approval
Post-Launch Ongoing Studies and Phase IV Clinical Trials
Electronic Health Records
Mobile Health Technologies
Recent Pharmaceutical and Bioinformatics Alliances and Partnerships
Conclusions
Chapter 12 Emerging Technologies and Developments
Introduction
Emerging Trends in Bioinformatics TechnologiesEmerging Trends in Bioinformatics Technologies
Data Science: The Era of New Technology
Soft Computing Approach
Challenges and Future Research Direction
Chapter 13 Qualitative Information on New Software
FastFinder
WorkFlow Language
Seven Bridges Platform
Chapter 14 M&A and Venture Funding Outlook
M&A Analysis
Research Grants
Public Funding
Private Funding
Chapter 15 Competitive Intelligence
Overview
Global Company Market Ranking Analysis
Chapter 16 Company Profiles
3RD MILLENNIUM INC.
AITIA
AGILENT TECHNOLOGIES INC.
ARAGEN LIFE SCIENCES LTD.
BIOMATTERS LTD. (GENEIOUS)
BIO-RAD (ABD SEROTEC)
BIO-TECHNE
COMPUGEN LTD.
DASSAULT SYSTEMES BIOVIA
DNASTAR INC.
GENEDATA AG
GENEVA BIOINFORMATICS (GENEBIO) SA
ILLUMINA INC.
INTE:LIGAND SOFTWARE ENTWICKLUNGS UND CONSULTING GMBH
